ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.470
+0.130 (9.70%)
At close: Mar 9, 2026, 4:00 PM EDT
1.460
-0.010 (-0.68%)
After-hours: Mar 9, 2026, 4:00 PM EDT
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $36.32 million as of March 9, 2026. Its market cap has increased by 377.94% in one year.
Market Cap
36.32M
Enterprise Value
35.84M
1-Year Change
377.94%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $36.32M, a decrease of -54.31%. That is a compound annual growth rate of -15.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 34.10M | -34.17% |
| Dec 31, 2025 | 51.80M | 572.73% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
| Aug 3, 2021 | 79.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PDS Biotechnology | 36.82M |
| NovaBay Pharmaceuticals | 36.31M |
| INmune Bio | 35.36M |
| Celularity | 34.89M |
| Outlook Therapeutics | 34.39M |
| Pluri | 32.97M |
| CEL-SCI | 31.89M |
| Rein Therapeutics | 31.54M |